Although fluctuating between 2000 and 2025, fertility rates generally decreased in all G7 countries in recent years. Italy and Japan were estimated to have the lowest fertility rates as of 2025, at *** children per woman of childbearing age. On the other hand, France had the highest rate at *** children. Interestingly, in Germany, the fertility rate was at the same level as Japan and Italy, but started to increase in 2013 and has remained slightly higher since. The fertility rate displays the average number of children a woman of child-bearing age in a country would have if she were to live to the end of her reproductive age.

Japan JP: Total Fertility Rate: Children per Woman data was reported at 1.300 Person in 2021. This records an increase from the previous number of 1.290 Person for 2020. Japan JP: Total Fertility Rate: Children per Woman data is updated yearly, averaging 1.375 Person from Dec 1990 (Median) to 2021, with 32 observations. The data reached an all-time high of 1.530 Person in 1991 and a record low of 1.270 Person in 2005. Japan JP: Total Fertility Rate: Children per Woman data remains active status in CEIC and is reported by Organisation for Economic Co-operation and Development. The data is categorized under Global Database’s Japan – Table JP.OECD.GGI: Social: Demography: OECD Member: Annual.

Between 1939 and 1950, Japan's annual fertility rate fluctuated between 3.1 and 4.4 births per woman, before spiking to 4.6 in 1947. This was the highest of the Axis powers listed, as European figures were generally much lower at this point in history. The increase in fertility that followed the Second World War was part of the global baby boom of the mid-twentieth century.

With 253,444 births, women aged 30 to 34 years were the leading age group giving birth in Japan in 2024. Overall, the number of live births in Japan added up to 686,173 in the year.

With an average of *** births per woman, Afghanistan had the highest fertility rate throughout the Asia-Pacific region in 2025. Pakistan and Papua New Guinea followed with the second- and third-highest fertility rates, respectively. In contrast, South Korea and Macao had the lowest fertility rates across the region. Contraception usage Fertility rates among women in the Asia-Pacific region have fallen throughout recent years. A likely reason is an increase in contraception use. However, contraception usage varies greatly throughout the Asia-Pacific region. Although contraception prevalence is set to increase across South Asia by 2030, women in both East Asia and Southeast Asia had higher contraception usage compared to South Asia in 2019. Women in APAC With the rise of feminism and the advancement of human rights, attitudes towards the role of women have changed in the Asia-Pacific region. Achieving gender equality has become a vital necessity for both men and women throughout the region. Alongside changes in traditional gender roles, women in certain Asia-Pacific countries, such as New Zealand, have become more inclined to marry later in life. Furthermore, the focus for younger women appears to be on having stability in their lives and securing an enjoyable job. This was displayed when female high school students in Japan were questioned about their future life aspirations.

Japan’s ongoing struggle with rapid ageing is well known. Fertility and migration policies have both been proposed as solutions to Japan’s ageing population. We used stock flow population models to estimate the impact of hypothetical fertility and migration policy interventions on measures of aging in Japan from 2015 to 2050. We evaluated policy models based on the Old Age Dependency Ratio (OADR) they produced at the specified end date. Start dates ranged from 2020 to 2030 to assess the time horizons of individual policies. Fertility policies were found to be highly time dependent and only slowed the rate of increase of OADR. It would require a Total Fertility Rate far above replacement levels to compensate for Japan’s already aged demography. Migration policy was less time dependent. However, such measures would require unprecedented, and ultimately unrealistic, volumes of migration over coming decades in order to reduce Japan’s OADR. Our results suggest that fertility and migration based policy responses will be unable to significantly reduce Japan’s OADR or reverse Japan’s ageing population within the next few decades. Japan should focus on activating its human capital through the prolongation of working lives, increasing participation, and improving productivity within the Japanese labour force to mitigate and adapt to the inevitable effects of ageing populations.

Japan JP: Birth Rate: Crude: per 1000 People data was reported at 7.800 Ratio in 2016. This records a decrease from the previous number of 8.000 Ratio for 2015. Japan JP: Birth Rate: Crude: per 1000 People data is updated yearly, averaging 10.800 Ratio from Dec 1960 (Median) to 2016, with 57 observations. The data reached an all-time high of 19.400 Ratio in 1973 and a record low of 7.800 Ratio in 2016. Japan JP: Birth Rate: Crude: per 1000 People data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Japan – Table JP.World Bank.WDI: Population and Urbanization Statistics. Crude birth rate indicates the number of live births occurring during the year, per 1,000 population estimated at midyear. Subtracting the crude death rate from the crude birth rate provides the rate of natural increase, which is equal to the rate of population change in the absence of migration.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision. (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

The average for 2022 based on 196 countries was 18.19 births per 1000 people. The highest value was in the Central African Republic: 45.42 births per 1000 people and the lowest value was in Hong Kong: 4.4 births per 1000 people. The indicator is available from 1960 to 2023. Below is a chart for all countries where data are available.

Japan IPSS: Median Mortality (MM): Low Birth Rate (LBR): Average Age data was reported at 56.600 NA in 2070. This records an increase from the previous number of 56.500 NA for 2069. Japan IPSS: Median Mortality (MM): Low Birth Rate (LBR): Average Age data is updated yearly, averaging 52.900 NA from Dec 2020 (Median) to 2070, with 51 observations. The data reached an all-time high of 56.600 NA in 2070 and a record low of 47.600 NA in 2020. Japan IPSS: Median Mortality (MM): Low Birth Rate (LBR): Average Age data remains active status in CEIC and is reported by National Institute of Population and Social Security Research. The data is categorized under Global Database’s Japan – Table JP.G005: 2023 Population Estimates: 2020 Census: National Institute of Population and Social Security Research.

The statistic shows the 20 countries with the lowest fertility rates in 2024. All figures are estimates. In 2024, the fertility rate in Taiwan was estimated to be at 1.11 children per woman, making it the lowest fertility rate worldwide. Fertility rate The fertility rate is the average number of children born per woman of child-bearing age in a country. Usually, a woman aged between 15 and 45 is considered to be in her child-bearing years. The fertility rate of a country provides an insight into its economic state, as well as the level of health and education of its population. Developing countries usually have a higher fertility rate due to lack of access to birth control and contraception, and to women usually foregoing a higher education, or even any education at all, in favor of taking care of housework. Many families in poorer countries also need their children to help provide for the family by starting to work early and/or as caretakers for their parents in old age. In developed countries, fertility rates and birth rates are usually much lower, as birth control is easier to obtain and women often choose a career before becoming a mother. Additionally, if the number of women of child-bearing age declines, so does the fertility rate of a country. As can be seen above, countries like Hong Kong are a good example for women leaving the patriarchal structures and focusing on their own career instead of becoming a mother at a young age, causing a decline of the country’s fertility rate. A look at the fertility rate per woman worldwide by income group also shows that women with a low income tend to have more children than those with a high income. The United States are neither among the countries with the lowest, nor among those with the highest fertility rate, by the way. At 2.08 children per woman, the fertility rate in the US has been continuously slightly below the global average of about 2.4 children per woman over the last decade.

BackgroundKawasaki disease (KD) is a common cause of acquired paediatric heart disease in developed countries. KD was first identified in the 1960s in Japan, and has been steadily increasing since it was first reported. The aetiology of KD has not been defined, but is assumed to be infection-related. The present study sought to identify the factor(s) that mediate the geographical variation and chronological increase of KD in Japan.Methods and FindingsBased upon data reported between 1979 and 2010 from all 47 prefectures in Japan, the incidence and mean patient age at the onset of KD were estimated. Using spatial and time-series analyses, incidence and mean age were regressed against climatic/socioeconomic variables. Both incidence and mean age of KD were inversely correlated with the total fertility rate (TFR; i.e., the number of children that would be born to one woman). The extrapolation of a time-series regressive model suggested that KD emerged in the 1960s because of a dramatic decrease in TFR in the 1940s through the 1950s.ConclusionsMean patient age is an inverse surrogate for the hazard of contracting the aetiologic agent. Therefore, the observed negative correlation between mean patient age and TFR suggests that a higher TFR is associated with KD transmission. This relationship may be because a higher TFR facilitates sibling-to-sibling transmission. Additionally, the observed inverse correlation between incidence and TFR implies a paradoxical “negative” correlation between the incidence and the hazard of contracting the aetiologic agent. It was hypothesized that a decreasing TFR resulted in a reduced hazard of contracting the agent for KD, thereby increasing KD incidence.

Snapshot img

Fertility Services Market Size 2025-2029

The fertility services market size is forecast to increase by USD 9.53 billion, at a CAGR of 7.8% between 2024 and 2029.

The market is a continually evolving landscape, driven by various factors that shape its dynamics. One significant trend is the increasing demand for fertility treatments due to the rising prevalence of late parenthood. According to recent studies, the number of women giving birth over the age of 35 has increased by 23.3% in the last decade. This demographic shift has led to a surge in demand for assisted reproductive technologies, including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Moreover, the market is also influenced by the growing incidence of prostate cancer, which can impact male fertility. According to the American Cancer Society, there will be approximately 193,000 new cases of prostate cancer diagnosed in the US in 2022.
This statistic underscores the importance of fertility services in addressing the reproductive health needs of cancer survivors. Despite these growth opportunities, the market faces challenges, including high complication rates associated with fertility treatments. For instance, the risk of multiple pregnancies and ovarian hyperstimulation syndrome (OHSS) are significant concerns. These complications can lead to increased healthcare costs and potential long-term health risks for patients. The market is a complex and dynamic industry, shaped by demographic trends, health concerns, and technological advancements. As the demand for fertility treatments continues to rise, stakeholders must navigate the challenges and opportunities that come with this evolving landscape.

Major Market Trends & Insights

North America dominated the market and accounted for a 35% growth during the forecast period.
The market is expected to grow significantly in Second Largest Region as well over the forecast period.
By the Service, the Treatment services sub-segment was valued at USD 6.65 billion in 2023
By the End-user, the Fertility clinics sub-segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 89.23 billion
Future Opportunities: USD USD 9.53 billion 
CAGR : 7.8%
North America: Largest market in 2023

What will be the Size of the Fertility Services Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

Fertility services encompass a range of medical interventions and technologies designed to help individuals and couples achieve pregnancy. One significant area within this market is the use of fertility medications, which play a crucial role in assisted reproductive technology (ART). According to recent reports, approximately 12% of women in the United States have used some form of fertility medication. ART involves various techniques, including artificial insemination, ovulation predictor kits, and ovarian stimulation protocols, among others. Cervical mucus plays a vital role in the natural process of conception, but ART may bypass this step through the use of intrauterine insemination (IUI) or in vitro fertilization (IVF).
In IUI, semen cryopreservation is essential for the success of the procedure. Ovarian stimulation protocols, such as ovulation induction, are commonly used in ART to increase the number of mature follicles and improve the chances of successful pregnancy. Ovulation predictor kits help individuals monitor their menstrual cycle and identify the most fertile days for conception. Despite the advancements in fertility services, challenges persist. Miscarriage rates remain a concern, with approximately 10-20% of known pregnancies ending in miscarriage. Blastocyst development is a critical factor in the success of ART, with implantation rate and pregnancy rate being essential indicators of treatment efficacy.
Reproductive endocrinology, a subspecialty of obstetrics and gynecology, focuses on the diagnosis and treatment of infertility. Donor insemination and ectopic pregnancy are other areas of fertility services that have gained increasing attention. Embryo culture media and ultrasound imaging are essential tools used in the field to monitor the development of embryos and assess the progress of pregnancies. Looking ahead, the market is expected to grow substantially. According to market reports, the global ART market is projected to expand at a significant rate, with an increase of around 15% in the number of ART cycles performed annually.
This growth is driven by factors such as rising infertility rates, increasing awareness, and advancements in technology. Comparing the growth rates of different regions, Asia Pacific is expected to witness the fastest growth in the ART market due to factors such as increasing disposable income, changing social norms, and government initiatives to promote fertility treatments

Japan JP: Death Rate: Crude: per 1000 People data was reported at 10.500 Ratio in 2016. This records an increase from the previous number of 10.300 Ratio for 2015. Japan JP: Death Rate: Crude: per 1000 People data is updated yearly, averaging 7.000 Ratio from Dec 1960 (Median) to 2016, with 57 observations. The data reached an all-time high of 10.500 Ratio in 2016 and a record low of 5.900 Ratio in 1979. Japan JP: Death Rate: Crude: per 1000 People data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Japan – Table JP.World Bank.WDI: Population and Urbanization Statistics. Crude death rate indicates the number of deaths occurring during the year, per 1,000 population estimated at midyear. Subtracting the crude death rate from the crude birth rate provides the rate of natural increase, which is equal to the rate of population change in the absence of migration.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision. (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

The current US Census Bureau world population estimate in June 2019 shows that the current global population is 7,577,130,400 people on earth, which far exceeds the world population of 7.2 billion from 2015. Our own estimate based on UN data shows the world's population surpassing 7.7 billion.

China is the most populous country in the world with a population exceeding 1.4 billion. It is one of just two countries with a population of more than 1 billion, with India being the second. As of 2018, India has a population of over 1.355 billion people, and its population growth is expected to continue through at least 2050. By the year 2030, the country of India is expected to become the most populous country in the world. This is because India’s population will grow, while China is projected to see a loss in population.

The next 11 countries that are the most populous in the world each have populations exceeding 100 million. These include the United States, Indonesia, Brazil, Pakistan, Nigeria, Bangladesh, Russia, Mexico, Japan, Ethiopia, and the Philippines. Of these nations, all are expected to continue to grow except Russia and Japan, which will see their populations drop by 2030 before falling again significantly by 2050.

Many other nations have populations of at least one million, while there are also countries that have just thousands. The smallest population in the world can be found in Vatican City, where only 801 people reside.

In 2018, the world’s population growth rate was 1.12%. Every five years since the 1970s, the population growth rate has continued to fall. The world’s population is expected to continue to grow larger but at a much slower pace. By 2030, the population will exceed 8 billion. In 2040, this number will grow to more than 9 billion. In 2055, the number will rise to over 10 billion, and another billion people won’t be added until near the end of the century. The current annual population growth estimates from the United Nations are in the millions - estimating that over 80 million new lives are added each year.

This population growth will be significantly impacted by nine specific countries which are situated to contribute to the population growth more quickly than other nations. These nations include the Democratic Republic of the Congo, Ethiopia, India, Indonesia, Nigeria, Pakistan, Uganda, the United Republic of Tanzania, and the United States of America. Particularly of interest, India is on track to overtake China's position as the most populous country by the year 2030. Additionally, multiple nations within Africa are expected to double their populations before fertility rates begin to slow entirely.

Global life expectancy has also improved in recent years, increasing the overall population life expectancy at birth to just over 70 years of age. The projected global life expectancy is only expected to continue to improve - reaching nearly 77 years of age by the year 2050. Significant factors impacting the data on life expectancy include the projections of the ability to reduce AIDS/HIV impact, as well as reducing the rates of infectious and non-communicable diseases.

Population aging has a massive impact on the ability of the population to maintain what is called a support ratio. One key finding from 2017 is that the majority of the world is going to face considerable growth in the 60 plus age bracket. This will put enormous strain on the younger age groups as the elderly population is becoming so vast without the number of births to maintain a healthy support ratio.

Although the number given above seems very precise, it is important to remember that it is just an estimate. It simply isn't possible to be sure exactly how many people there are on the earth at any one time, and there are conflicting estimates of the global population in 2016.

Some, including the UN, believe that a population of 7 billion was reached in October 2011. Others, including the US Census Bureau and World Bank, believe that the total population of the world reached 7 billion in 2012, around March or April.

Japan JP: Lifetime Risk of Maternal Death: 1 in: Rate Varies by Country data was reported at 13,400.000 NA in 2015. This records an increase from the previous number of 13,200.000 NA for 2014. Japan JP: Lifetime Risk of Maternal Death: 1 in: Rate Varies by Country data is updated yearly, averaging 8,800.000 NA from Dec 1990 (Median) to 2015, with 26 observations. The data reached an all-time high of 13,400.000 NA in 2015 and a record low of 5,200.000 NA in 1990. Japan JP: Lifetime Risk of Maternal Death: 1 in: Rate Varies by Country data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Japan – Table JP.World Bank: Health Statistics. Life time risk of maternal death is the probability that a 15-year-old female will die eventually from a maternal cause assuming that current levels of fertility and mortality (including maternal mortality) do not change in the future, taking into account competing causes of death.; ; WHO, UNICEF, UNFPA, World Bank Group, and the United Nations Population Division. Trends in Maternal Mortality: 1990 to 2015. Geneva, World Health Organization, 2015; Weighted average;

BackgroundBirth weights have continued to decline in Japan in recent years. However, secular trend changes such as the birth weight relative to the week of gestation remain to be explored. This study aimed to determine the trends over time in mean birth weight and small for gestational age (SGA) rate for each gestational week.MethodsWe used a large dataset of 27,015,792 births obtained from birth certificates between 1997 and 2021. Births from 22 to 41 weeks of gestation were evaluated in six groups (22–24, 25–27, 28–31, 32–33, 34–36, and 37–41 weeks of gestational age). For each group, secular trend changes in the z-scores calculated from standard birth weight values were assessed. Time trends in the proportion of SGA and mean birth weight z-scores were evaluated using the Cochran–Armitage trend test and linear regression analysis. Binomial logistic regression was performed to ascertain the effects of gestational age, sex, primiparity, number of births, and maternal age on the likelihood of SGA.ResultsThe mean birth weight of preterm infants continued to decrease, and the z-score for mean birth weight decreased linearly, falling to −0.7 at 25–27 weeks of gestation from 1997–2001 (first period) to 2017–2021 (final period). Maternal age continued to increase from the first period to the last period for all weeks of gestation. There was a linear increase in the SGA rate in preterm infants born at

In 1800, the population of Japan was just over 30 million, a figure which would grow by just two million in the first half of the 19th century. However, with the fall of the Tokugawa shogunate and the restoration of the emperor in the Meiji Restoration of 1868, Japan would begin transforming from an isolated feudal island, to a modernized empire built on Western models. The Meiji period would see a rapid rise in the population of Japan, as industrialization and advancements in healthcare lead to a significant reduction in child mortality rates, while the creation overseas colonies would lead to a strong economic boom. However, this growth would slow beginning in 1937, as Japan entered a prolonged war with the Republic of China, which later grew into a major theater of the Second World War. The war was eventually brought to Japan's home front, with the escalation of Allied air raids on Japanese urban centers from 1944 onwards (Tokyo was the most-bombed city of the Second World War). By the war's end in 1945 and the subsequent occupation of the island by the Allied military, Japan had suffered over two and a half million military fatalities, and over one million civilian deaths.

The population figures of Japan were quick to recover, as the post-war “economic miracle” would see an unprecedented expansion of the Japanese economy, and would lead to the country becoming one of the first fully industrialized nations in East Asia. As living standards rose, the population of Japan would increase from 77 million in 1945, to over 127 million by the end of the century. However, growth would begin to slow in the late 1980s, as birth rates and migration rates fell, and Japan eventually grew to have one of the oldest populations in the world. The population would peak in 2008 at just over 128 million, but has consistently fallen each year since then, as the fertility rate of the country remains below replacement level (despite government initiatives to counter this) and the country's immigrant population remains relatively stable. The population of Japan is expected to continue its decline in the coming years, and in 2020, it is estimated that approximately 126 million people inhabit the island country.

Japan JP: Life Expectancy at Birth: Male data was reported at 80.980 Year in 2016. This records an increase from the previous number of 80.750 Year for 2015. Japan JP: Life Expectancy at Birth: Male data is updated yearly, averaging 75.630 Year from Dec 1960 (Median) to 2016, with 57 observations. The data reached an all-time high of 80.980 Year in 2016 and a record low of 65.310 Year in 1960. Japan JP: Life Expectancy at Birth: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Japan – Table JP.World Bank: Health Statistics. Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision. (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

Snapshot img

The infertility drugs market share is expected to increase by USD 1.03 billion from 2019 to 2024, and the market’s growth momentum will accelerate at a CAGR of 4.82%.

This infertility drugs market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers infertility drugs market segmentations by product (hormone-based therapy and others) and geography (North America, Europe, APAC, and South America). The infertility drugs market report also offers information on several market vendors, including AbbVie Inc., Allergan Plc, Bayer AG, Ferring Pharmaceuticals AS, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi among others.

What will the Infertility Drugs Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Infertility Drugs Market Size for the Forecast Period and Other Important Statistics

Infertility Drugs Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The growing lifestyle diseases is notably driving the infertility drugs market growth, although factors such as rising inclination toward other modes of treatment for infertility may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the infertility drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Infertility Drugs Market Driver

The rising trend of late parenthood is a key driving factor impacting the global infertility drugs market growth. Increased age of parenthood is one of the major factors leading to the infertility problem in the present generation. In fact, it has severely affected European countries and some Asian countries such as Japan. This growing trend of late motherhood is against the natural range of fertile years for women, which significantly brightens the prospects for the global infertility drugs market. Factors such as the growing use of various contraceptive technologies, increasing focus on higher education and career, and urbanization have led to the rising median age of first pregnancy, leading to falling fertility rates. Globally, more women are working than ever before, which has also increased the average age of conceiving a child. Such factors are creating more complications and often lead to infertility.

Key Infertility Drugs Market Trend

Raising awareness regarding infertility in couples is a key trend impacting the global infertility drugs market growth. There is growing awareness about sexual health, such as fertility issues across the globe. This is expected to act as a positive trend in the infertility treatment industry. Different government and non-government organizations across the globe are supporting the couples to come forward and discuss their problems and seek professional help to tackle their issues. For instance, the International Fertility Alliance (IFA) is on a mission to spread awareness about fertility issues and provide support to people with fertility-related issues. Additionally, the National Fertility Association founded the National Infertility Awareness Week, which focuses on providing the right information and answering queries about infertility.

Key Infertility Drugs Market Challenge

The rising inclination toward other modes of treatment for infertility is a key challenge negatively impacting the global infertility drugs market growth. Rising preference for other modes of treatment such as assisted reproductive technology (ART) is posing tough competition for the infertility drugs market. In developed countries, couples having problems conceiving children are inclining toward ART. IVF is the most adopted form of ART treatment. Some of the other forms of treatment for infertility are listed below. Artificial insemination/Intrauterine insemination (IUI) involves direct injection of sperm into the uterus via a thin, flexible catheter. Couples that face low sperm count in the male partner opt for such treatments.

This infertility drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2020-2024.

Parent Market Analysis

Technavio categorizes the global Infertility drugs market is a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the infertility drugs

Snapshot img

Assisted Reproductive Technology (ART ) Market Size 2024-2028

The assisted reproductive technology (ART ) market size is valued to increase by USD 6.3 billion, at a CAGR of 4.36% from 2023 to 2028. Increase in rate of infertility and obesity-related cases will drive the assisted reproductive technology (ART ) market.

Major Market Trends & Insights

Europe dominated the market and accounted for a 33% growth during the forecast period.
By End-User - Fertility clinics segment was valued at USD 13.88 billion in 2022
By Type - IVF segment accounted for the largest market revenue share in 2022

Market Size & Forecast

Market Opportunities: USD 45.53 million
Market Future Opportunities: USD 6295.30 million
CAGR from 2023 to 2028 : 4.36%

Market Summary

The market: Global Trends and Challenges The market is experiencing significant growth due to the increasing prevalence of infertility and obesity-related cases, as well as the rising number of single-parent families seeking parenthood. ART , which includes in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and other related techniques, offers hope to millions of couples worldwide who face fertility supplements challenges. One notable trend in the ART market is the focus on improving operational efficiency and reducing side effects of treatment. For instance, clinics are implementing advanced technologies such as time-lapse imaging and automated embryo grading systems to optimize embryo selection and increase the chances of successful implantation.
These innovations have led to a reduction in the number of embryos transferred per cycle, thereby decreasing the risk of multiple pregnancies and associated complications. Moreover, regulatory compliance is a significant challenge in the ART market. Strict regulations governing the use of ART , pART icularly in developing countries, can hinder market growth. For example, a clinic might face delays in obtaining necessary permits or face penalties for non-compliance. To address this challenge, some clinics are investing in compliance management systems to ensure adherence to local and international regulations. A real-world business scenario illustrates the importance of operational efficiency and compliance in the ART market.
A large fertility clinic implemented an automated embryo grading system, resulting in a 25% reduction in embryo transfer failures and a 15% increase in successful pregnancies. Additionally, the clinic invested in a compliance management system, enabling it to streamline regulatory reporting and reduce the risk of penalties. These improvements led to increased patient satisfaction and a stronger reputation in the market.

What will be the Size of the Assisted Reproductive Technology (ART ) Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Assisted Reproductive Technology (ART ) Market Segmented ?

The assisted reproductive technology (ART ) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-User

  Fertility clinics
  Hospitals
  Surgical centers
  Research institutes/labs
  Cryobanks


Type

  IVF
  ART ificial insemination
  GIFT (Gamete Intrafallopian Transfer)
  ZIFT (Zygote Intrafallopian Transfer)
  Surrogacy
  Donor egg/sperm ART


Product

  Instrument
  Accessory and Disposable
  Reagents and Media
  Software


Geography

  North America

    US


  Europe

    France
    Germany
    Netherlands
    UK


  Middle East and Africa

    UAE


  APAC

    China
    India
    Japan


  South America

    Brazil


  Rest of World (ROW)

By End-User Insights

The fertility clinics segment is estimated to witness significant growth during the forecast period.

Fertility clinics dominated the global assisted reproductive technology (ART) market owing to a worldwide increase in the number of fertility centers to meet the unmet and growing demand of infertility patients. This rise has subsequently increased the consumption of ART solutions, including IVF procedures, artificial insemination, gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT). A key factor influencing the inflow of infertility patients is the high improvement in the pregnancy success rates, particularly as clinics optimize ovarian stimulation protocols, embryo transfer techniques, and preimplantation genetic testing (PGT).

Generally, in a fertility clinic, success rates are measured by the number of treatments carried out and the corresponding clinical pregnancy rate or live birth rate. The implantation rate, embryo morphology, and endometrial receptivity are all critical determinants of treatment eff